BIFIDO Co., Ltd. (KOSDAQ:238200)
South Korea · Delayed Price · Currency is KRW 2,360.00
-20.00 (-0.84%)
At close: Nov 13, 2026
BIFIDO Market Cap
BIFIDO has a market cap or net worth of 19.3 billion as of November 13, 2026. It is the 39,085th most valuable company in the world and the 2,434th biggest in South Korea. Its market cap has decreased by 35.25% in one year.
Market Cap
19.30B
Enterprise Value
21.91B
Revenue
14.63B
Global Rank
Country Rank
#2,434 South Korea
PE Ratio
10.42
ChartMarket Cap Chart
Since December 26, 2018, BIFIDO's market cap has decreased from 149.29B to 19.30B, a decrease of -87.07%. That is a compound annual growth rate of -22.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 19.30B | -23.00% |
| Dec 30, 2025 | 25.07B | 4.07% |
| Dec 30, 2024 | 24.09B | -45.16% |
| Dec 28, 2023 | 43.93B | -36.82% |
| Dec 29, 2022 | 69.53B | -22.02% |
| Dec 30, 2021 | 89.16B | -4.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HLscience | 30.46B |
| Kyung Nam Pharm | 29.47B |
| Korea Arlico Pharm | 28.29B |
| Pharmsville | 25.97B |
| Baskhanbio Pharma | 22.53B |
| Seoul Pharma | 20.35B |
| Union Korea Pharm | 19.70B |
| Daesung Microbiological Labs. | 19.46B |